本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trinity Biotech plc

6.60
-0.2550-3.72%
成交量:2.20万
成交额:16.05万
市值:536.65万
市盈率:-0.11
高:7.69
开:7.09
低:6.53
收:6.86
52周最高:52.50
52周最低:5.01
股本:81.31万
流通股本:66.91万
量比:1.16
换手率:3.29%
股息:- -
股息率:- -
每股收益(TTM):-60.3628
每股收益(LYR):-60.3628
净资产收益率:-1913.45%
总资产收益率:-5.72%
市净率:-0.07
市盈率(LYR):-0.11

数据加载中...

2023/05/17

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/09/12

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/25

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/23

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/02

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/17

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/09/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]